Literature DB >> 12709925

Assessment of uterine placental circulation in thrombophilic women.

Zeev Weiner1, Johnny S Younis, Zeev Blumenfeld, Eliezer Shalev.   

Abstract

Thrombophilia is associated with several complications of pregnancy including first and second trimester fetal loss, intrauterine fetal death, intrauterine growth restriction, preeclampsia, and placental abruption. Few studies have documented thrombotic lesions observed on the pathologic examination of the placenta in women with severe pregnancy complications. Moreover, a significantly higher rate of factor V Leiden and prothrombin G20210A gene mutations have been found in placentas with thrombotic events compared with normal placentas. In addition, clinical studies have been performed, using Doppler ultrasonography, to assess the uterine placental circulation in women with thrombophilia. Doppler studies of the umbilical artery in cases of intrauterine growth retardation have shown a high systolic to diastolic ratio (S/D) ratio, suggesting an increase in the resistance of the placental small vessels. When these placental vessels were examined after delivery, significant differences were found in comparison with placental vessels of normal pregnancies. Most of the Doppler studies of the umbilical and uterine arteries in pregnancies with thrombophilia were performed in women with antiphospholipid antibodies. The other pathologic conditions associated with thrombophilia and complications of pregnancy were published only recently. These few studies have demonstrated abnormal umbilical and uterine arteries blood flow in complicated pregnancies. Finally, few Doppler studies also suggest improved uterine placental circulation when women with thrombophilia received thromboprophylaxis.

Entities:  

Mesh:

Year:  2003        PMID: 12709925     DOI: 10.1055/s-2003-38837

Source DB:  PubMed          Journal:  Semin Thromb Hemost        ISSN: 0094-6176            Impact factor:   4.180


  4 in total

1.  Antiangiogenic effects of decorin restored by unfractionated, low molecular weight, and nonanticoagulant heparins.

Authors:  Amy K L Chui; Tilini N Gunatillake; Vera Ignjatovic; Paul T Monagle; Padma Murthi; Shaun P Brennecke; John M Whitelock; Joanne M Said
Journal:  Blood Adv       Date:  2017-07-03

2.  3-D volumetric MRI evaluation of the placenta in fetuses with complex congenital heart disease.

Authors:  Nickie Andescavage; Alexa Yarish; Mary Donofrio; Dorothy Bulas; Iordanis Evangelou; Gilbert Vezina; Robert McCarter; Adre duPlessis; Catherine Limperopoulos
Journal:  Placenta       Date:  2015-07-06       Impact factor: 3.481

3.  Comparison of 2 approaches in management of pregnant women with inherited trombophilias: Prospective analytical cohort study.

Authors:  Stefan Dugalic; Milos Petronijevic; Aleksandar Stefanovic; Katarina Stefanovic; Svetlana Vrzic Petronijevic; Dejana Stanisavljevic; Sonja Perkovic Kepeci; Nemanja Milincic; Igor Pantic; Milan Perovic
Journal:  Medicine (Baltimore)       Date:  2019-08       Impact factor: 1.817

4.  Low-molecular-weight heparin for prevention of placenta-mediated pregnancy complications: protocol for a systematic review and individual patient data meta-analysis (AFFIRM).

Authors:  Marc A Rodger; Nicole J Langlois; Johanna Ip de Vries; Evelyne Rey; Jean-Christophe Gris; Ida Martinelli; Ekkehard Schleussner; Timothy Ramsay; Ranjeeta Mallick; Becky Skidmore; Saskia Middeldorp; Shannon Bates; David Petroff; Dick Bezemer; Marion E van Hoorn; Carolien Nh Abheiden; Annalisa Perna; Paulien de Jong; Risto Kaaja
Journal:  Syst Rev       Date:  2014-06-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.